Fig. 4From: Serum leucine-rich alpha-2-glycoprotein-1 with fucosylated triantennary N-glycan: a novel colorectal cancer markerResponse to chemotherapy and change in LRG–FTG, CEA, and combination values within 6 months for surgery or chemotherapy. PR, partial response; SD, stable disease; PD, progressive diseaseBack to article page